Cargando…
A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474885/ https://www.ncbi.nlm.nih.gov/pubmed/37662884 http://dx.doi.org/10.2478/jtim-2023-0097 |
_version_ | 1785100601547292672 |
---|---|
author | Liu, Yang Duan, Wenbing Huang, Xiaojun Lu, Jin |
author_facet | Liu, Yang Duan, Wenbing Huang, Xiaojun Lu, Jin |
author_sort | Liu, Yang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10474885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-104748852023-09-03 A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma Liu, Yang Duan, Wenbing Huang, Xiaojun Lu, Jin J Transl Int Med Letter to Editor De Gruyter 2023-09-02 /pmc/articles/PMC10474885/ /pubmed/37662884 http://dx.doi.org/10.2478/jtim-2023-0097 Text en © 2023 Yang Liu, Wenbing Duan, Xiaojun Huang, Jin Lu, published by De Gruyter on behalf of Scholar Media Publishing https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. |
spellingShingle | Letter to Editor Liu, Yang Duan, Wenbing Huang, Xiaojun Lu, Jin A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma |
title | A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma |
title_full | A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma |
title_fullStr | A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma |
title_full_unstemmed | A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma |
title_short | A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma |
title_sort | first case report of using chimeric antigen receptor t-cell immunotherapy to treat high-risk smoldering multiple myeloma |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474885/ https://www.ncbi.nlm.nih.gov/pubmed/37662884 http://dx.doi.org/10.2478/jtim-2023-0097 |
work_keys_str_mv | AT liuyang afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT duanwenbing afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT huangxiaojun afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT lujin afirstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT liuyang firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT duanwenbing firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT huangxiaojun firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma AT lujin firstcasereportofusingchimericantigenreceptortcellimmunotherapytotreathighrisksmolderingmultiplemyeloma |